Birgitte Volck

No open positions remaining

Net worth: 7 238 $ as of 2026-07-30

63 year

74 connections

Health Technology

Commercial Services

Consumer Services

Profile

Currently, Birgitte Volck holds the position of SVP, Head-Clinical Development & Medical Affairs at Ascendis Pharma A. Dr. Volck is also on the board of Soleno Therapeutics, Inc. and Vaccibody AS. Dr. Volck previously occupied the position of Head-Research & Development at GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development at Swedish Orphan Biovitrum AB, President-Research & Development at Avrobio, Inc., Director-Executive Development at Amgen, Inc., Director-Nordic Medical & Project Director at Genzyme Danmark and Head-Clinical Development & Medical Affairs at Pharmexa A. Birgitte Volck received a doctorate from the University of Copenhagen.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NYKODE THERAPEUTICS ASA 0.01%	2024-12-30	20,311 ( 0.01% )	7 238 $	2026-07-30

Former positions of Birgitte Volck

Companies	Position	End
SOLENO THERAPEUTICS, INC.	Director/Board Member	2026-05-14
OMass Therapeutics Ltd. OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform	Director/Board Member	2026-01-27
NYKODE THERAPEUTICS	Director/Board Member	2024-12-29
ASCENDIS PHARMA A/S	Chief Tech/Sci/R&D Officer	2023-11-30
TECTONIC THERAPEUTIC, INC.	Chief Tech/Sci/R&D Officer	2020-09-30

See the detail of Birgitte Volck's experience

Training of Birgitte Volck

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Birgitte Volck's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Soleno Therapeutics, Inc. Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Pharmexa A/S Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs	Health Technology
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
TFS Trial Form Support AB TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services Provides clinical trial and contract research services	Commercial Services
Ascendis Pharma A/S Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology	Health Technology
Nykode Therapeutics ASA Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer	Health Technology
TFS Trial Form Support International AB TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services Operates as clinical contract research organization	Commercial Services
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care	Health Technology
Genzyme Danmark
Wilson Therapeutics AB Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company focusing in treatment of Wilson disease	Health Technology
AVROBIO, Inc. AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose	Health Technology
OMass Therapeutics Ltd. OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform	Commercial Services